Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
They published their findings recently in the Journal of Virology.
Researchers from UGA and Sanofi Pasteur, which has a research and development collaboration agreement with UGA, will present their data tomorrow, March 30, at the World Vaccine Congress US 2016 in Washington, D.C.
“One of the problems with current influenza vaccines is that we have to make predictions about which virus strains will be most prevalent every year and build our vaccines around those predictions,” said Ted Ross, director of UGA’s Center for Vaccines and Immunology and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine. “What we have developed is a vaccine that protects against multiple different strains of H1N1 virus at once, so we might be able to one day replace the current standard of care with this more broadly cross-protective vaccine.”
The H1N1 influenza virus caused a worldwide pandemic in 2009. When it was first detected, it was called swine flu because the virus was similar to those found in pigs, but the virus now circulates as a seasonal form of influenza.
Using a technique called Computationally Optimized Broadly Reactive Antigen, or COBRA, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley, along with Ross, created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.
The COBRA vaccines were designed to recognize H1N1 viruses isolated within the last 100 years, but many of the experimental vaccines produced immunity against influenza strains not included in the design. This means that scientists may be able to produce a vaccine that not only protects against recognized seasonal and pandemic influenza strains, but also strains that have yet to be discovered.
Because this vaccine is generated from the genetic sequences of multiple flu viruses, it may protect against many strains over several years, Ross said. That would also allow for year-round manufacturing of the vaccine, since scientists would not have to halt production every year to identify the most prevalent strains.
This research is part of a broader effort to create a universal influenza vaccine, which would protect against all strains of the virus.
“We still have some work to do before we get a truly universal flu vaccine,” Ross said. “But the COBRA vaccine we’ve developed for H1N1 virus subtypes is a major step in the right direction.”
The Latest on: Flu vaccine
No news articles
via Google News
The Latest on: Flu vaccine
- COVID-19 Vaccine Distribution Builds on Pandemic Flu Planon June 26, 2020 at 2:04 pm
Developing a SARS-CoV-2 vaccine and distribution plan is an 'insurmountable task' but can be done with timely planning that builds on lessons learned during the 2009 H1N1 influenza pandemic.
- Hector S. Izurieta, MD, MPH, PhD, on Flu Vaccine Strategieson June 26, 2020 at 1:33 pm
The lead study author, Hector S. Izurieta, MD, MPH, PhD, of the FDA's Center for Biologics Evaluation and Research, discussed the results and their significance in greater detail. During the 2018-2019 ...
- Estimating COVID-19 spread by looking at past trends of influenza-like illnesseson June 26, 2020 at 12:14 pm
In order to better understand the spread of the novel coronavirus, new research examines trends in visits to outpatient clinics for influenza-like illnesses in March 2020 as compared to previous years ...
- Flu Vaccine Only 39% Effective This Past Season, CDC Panel Sayson June 25, 2020 at 12:48 pm
The influenza vaccine was even less effective against A/H1N1pmd09 virus but was better against B/Victoria virus, according to a CDC panel. They also voted on a new meningococcal vaccine.
- Mass. stepping up flu vaccine pushon June 25, 2020 at 10:10 am
The Baker administration is planning to work with schools and municipalities to get more people to get a flu shot this fall, when cold and flu season is poised to overlap with ongoing efforts to fight ...
- Baker Administration stepping up flu vaccine pushon June 25, 2020 at 10:02 am
For the 2018–19 influenza season, Massachusetts had the highest rate of vaccination among children between six months and 17 years old. The U.S. Centers for Disease Control said the state had ...
- Misconceptions, lack of targeted communication key reasons for low flu vaccine uptake in Aboriginal adultson June 25, 2020 at 5:46 am
Widespread misconceptions seem to be a barrier to Aboriginal people accessing the flu vaccine, according to a new study by UNSW public health researchers published today in the Australian and New ...
- CDC, major vaccine manufacturers ramp up production of flu shots as the US braces for the potential simultaneous impact of the coronavirus and the seasonal fluon June 25, 2020 at 12:24 am
One health official emphasized the need for more flu vaccines because "that's one less virus that could kill 20, 30, 50,000, 70,000 [people]." ...
- CDC, drugmakers boost flu vaccine doses amid fears of an unprecedented respiratory illness seasonon June 24, 2020 at 2:40 pm
Worried about a simultaneous assault of the novel coronavirus and seasonal influenza this winter, public health officials and vaccine manufacturers are making millions of extra flu vaccine doses to ...
- Flu Vaccine Was Disappointing Vs. Some Strains Last Seasonon June 24, 2020 at 2:37 pm
U.S. health officials say the flu vaccine did a disappointing job last winter, and officials worry it might be a bad sign for the fall.
via Bing News